Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects

The pharmacokinetics and safety of biapenem were studied in 36 healthy adult subjects in a randomized, placebo-controlled, double blind, sequential single- and multiple-ascending-dose study using doses from 250 to 1,250 mg administered three times a day using 3-h infusions. Maximum concentrations fo...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Griffith, David C., Morgan, Elizabeth E., Dudley, Michael N., Loutit, Jeffery S.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2021
Subjects:
Pharmacology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092883/
https://ncbi.nlm.nih.gov/pubmed/33685898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02612-20
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items